B Capital Group

B Capital is a global multi-stage investment firm founded in 2015 by Eduardo Saverin and Raj Ganguly. It focuses on supporting early to late-stage innovators in technology-driven sectors including healthcare and biotech. The firm has raised over $8 billion in assets under management and operates globally with nine offices across the US and Asia. In 2023 it closed its inaugural dedicated healthcare fund ($500M+), investing in digital health, biotech, medtech and healthtech companies at various stages of development. Its healthcare investments include AI-enabled drug discovery firms like Hotspot Therapeutics and cell therapy platforms such as Triumvira.